Patents Represented by Attorney Peter L. Herridge

Find this attorney in the Justia Lawyer Directory

  • Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonists
    Patent number: 8017614
    Abstract: This invention relates to a novel arylindenopyrimidine, A, and its therapeutic and prophylactic uses. Disorders treated and/or prevented include Parkinson's Disease.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: September 13, 2011
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Brian C. Shook, Paul F. Jackson
  • Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
    Patent number: 7087643
    Abstract: This invention is directed to a method for preventing or treating neuropathic pain and cluster and migraine headache-associated pain comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I): wherein phenyl is substituted at X with one to five halogen atoms independently selected from the group consisting of fluorine, chlorine, bromine and iodine; and; R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1–C4 alkyl; wherein C1–C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of hydrogen, halogen, C1–C4 alkyl, C1–C4 alkoxy, amino, nitro and cyano).
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: August 8, 2006
    Assignee: Ortho-McNeil Pharmaceutical Inc.
    Inventors: Ellen C. Codd, Carlos R. Plata-Salaman, Boyu Zhao
  • Carbamate compounds for use in preventing or treating anxiety disorders
    Patent number: 7078436
    Abstract: This invention is directed to a method for preventing or treating anxiety disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: July 18, 2006
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Carlos R. Plata-Salaman, Boyu Zhao, Roy E. Twyman
  • Arylindenopyridines and related therapeutic and prophylactic methods
    Patent number: 6903109
    Abstract: This invention provides novel arylindenopyridines of the formula: and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing Adensine A2a receptors or reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: June 7, 2005
    Assignee: Ortho-Muniel Pharmaceutical, Inc.
    Inventors: Geoffrey R. Heintzelman, Kristin M. Averill, John H. Dodd, Keith T. Demarest, Yuting Tang, Paul F. Jackson